Renal cell carcinoma: New prognostic factors?

Current Opinion in Urology

Volumn 13, Issue 6, 2003, Pages 433-438

  Kirkali, Ziya ^a   Lekili, Murat ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Grade; Prognosis; Renal cell carcinoma; Stage

Indexed keywords

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALGORITHM; ANGIOGENESIS; APOPTOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE MARKER; GENDER; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; KIDNEY CARCINOMA; NEPHRECTOMY; OUTCOMES RESEARCH; PARANEOPLASTIC SYNDROME; PATHOLOGY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ADULT; AGE FACTORS; AGED; ALGORITHMS; CARCINOMA, RENAL CELL; FEMALE; GENETIC MARKERS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0442292067     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200311000-00002     Document Type: Review

References (79)

1. Kirkali Z, Tuzel E, Mungan MU. Recent advances in kidney cancer and metastatic disease. BJU Int 2001; 88:818-824.
2. Kirkali Z, Tuzel E, Mungan MU. Prognostic factors for renal cell carcinoma. In: Bangma ChH, Newling DWW, editors. PACIOU VII prostate and renal cancer, benign prostatic hyperplasia, erectile dysfunction and basic research. An update. Boca Raton: Parthenon; 2003. Chapter 35, pp. 291-303. This is a recent review of the various prognosticators in RCC, and updates the recent findings of numerous clinical, pathological and biochemical studies.
3. Belldegrun A, deKernion JB. Renal tumors. In: Walsh PC, Retik AB, Vaughn ED Jr, et al., editors. Campbell's urology. 7th ed. Philadelphia: WB Saunders; 1998. Vol. 3, Chapter 76, pp. 2283-2326.
4. Van Poppel H, Beckers G, Baert L. Renal cell carcinoma. In: Gospodarowicz MK, Henson DE, Hutter RVP et al., editors. Prognostic factors in cancer (UICC). Wiley-Liss; 2001. Chapter 39, pp. 609-626.
5. Sejima T, Miyagawa I. Expression of bcl-2, p53 oncoprotein and proliferating cell nuclear antigen in renal cell carcinoma. Eur Urol 1999; 35:242-248.
6. Delahunt B, Bethwaite PB, Nacey JN, et al. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumor grade, mitotic index and silver-staining nucleolar organizer region numbers. J Pathol 1993; 170:471-473.
7. Kirkali G, Tuzel E, Guler C, et al. Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder. Eur Urol 2001; 39:292-299.
8. Aaltomaa S, Lipponen P, Ala-Opas M, et al. Prognostic value of Ki-67 expression in renal cell carcinoma. Eur Urol 1997; 31:350-355.
9. Yoshida K, Tosaka A, Takeuchi S, et al. Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 1994; 73:1913-1918.
10. Tuzel E, Kirkali Z, Yorukoglu K, et al. Metallothionein expression in renal cell carcinoma: subcellular localization and prognostic significance. J Urol 2001; 165:1710-1713.
11. McLennan G, Bostwick D. Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 1995; 46:27-30.
12. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002; 26:281-291. This paper outlines the prognostic importance of histological patterns in RCC.
13. Ljungberg B, Alamdari FI, Stenling R, et al. Prognostic significance of the Heidelberg classification of RCC. Eur Urol 1999; 36:565-569.
14. Bostwick DG, Eble JN. Urological surgical pathology. 1st ed. St Louis: Mosby; 1997. pp. 90-92.
15. Delahunt B, Eble JN. Papillary renal carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997; 10:537-544.
16. Delahunt B, Eble JN, McCredie MRE, et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001; 32:590-595.
17. Leroy X, Zini L, Leteurtre E, et al. Morphologic subtyping of papillary RCC: correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol 2002; 15:1126-1130.
18. Motzer RJ, Bacik J, Mariani T, et al. Treatment outcome and survival associated with metastatic RCC of non-clear-cell histology. J Clin Oncol 2002; 20:2376-2381.
19. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumors. J Pathol 1997; 183:131-133.
20. Amnon Z, Chao DH, Pantuck AJ, et al. Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype. J Urol 2002; 168:950-955.
21. Mian BM, Bhadkamkar N, Slaton JW, et al. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 2002; 167:65-70.
22. Onishi T, Oishi Y, Yanada S, et al. Prognostic implications of histological features in patients with chromophobe cell renal carcinoma. BJU Int 2002; 90:529-532.
23. Said JW, Thomas G, Zisman A. Kidney pathology. Current classification of renal cell carcinoma. Curr Urol Rep 2002; 3:25-30. This provides an elegant description of the pathological classification of RCC. It also gives satisfactory information about the prognostic value of different pathological subtypes.
24. Mani S, Todd MB, Katz K, et al. Prognostic factors for survival in patients with metstatic renal cancer treated with biologic response modifiers. J Urol 1995; 154:35-40.
25. Kankuri M, Pelliniemi TT, Pyrhone S, et al. Feasibility of prolonged use of interferon-alfa in metastatic kidney carcinoma: a phase II study. Cancer 2001; 92:761-767.
26. Tsui KH, Shvarts O, Smith RB, et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using revised 1997 TNM staging criteria. J Urol 2000; 163:1090-1095.
27. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166:1611-1623.
28. Fiori E, DeCesare A, Galati G, et al. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with RCC. J Exp Clin Cancer Res 2002; 21:229-231.
29. Uzzo RG, Cherullo EE, Myles J, Novick AC. Renal cell carcinoma invading the urinary collecting system: implications for staging. J Urol 2002; 167:2392-2396.
30. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6:655-663.
31. Ozer E, Yorukoglu K, Sagol O, et al. Prognostic significance of nuclear morphometry in renal cell carcinoma. BJU Int 2002; 90:20-25.
32. Baltaci S, Orhan D, Soyupek S, et al. Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma. J Urol 2000; 164:36-39.
33. Guinan P, Sobin LH, Algaba F, et al. TNM staging of renal cell carcinoma. Diagnosis and prognosis of renal cell carcinoma: 1997 Workshop. American Cancer Society. Cancer 1997; 80:992-993.
34. Ljunberg B, Alamdari FI, Rasmuson T, Roos G. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastasis after radical nephrectomy. BJU Int 1999; 84:405-411.
35. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999; 162:1930-1933.
36. Delahunt B, Kittelson JM, McCredie MR, et al. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer 2002; 94:658-664. This is an excellent critique of the 1997 tumor-node metastasis classification of RCC.
37. Zucchi A, Mearini L, Mearini E, Constantini E. Stage pT1 renal cell carcinoma: review of the prognostic significance of size. Urol Int 2003; 70:47-50.
38. Sobin LH, Wittekind CH (2002). UICC-TNM classification of malignant tumours. New York: Wiley-Liss.
39. Yusim I, Mermershtain W, Neulander E, et al. Influence of age on the prognosis of patients with renal cell carcinoma (RCC). Onkologie 2002; 25:548-550.
40. Rodriguez A, Patard JJ, Lobel B. Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature. Arch Esp Urol 2002; 55:969-975.
41. Griffiths DFR, Verghese A, Golash A, et al. Contribution of grade, vascular invasion and age to outcome in clinically localized RCC. BJU Int 2002; 90:26-31.
42. Onishi T, Oishi Y, Goto H, et al. Gender as a prognostic factor in patients with RCC. BJU Int 2002; 90:32-36.
43. Mitsumori K, Kittleson JM, Itoh N, et al. Chromosome 14q LOH in localized clear cell carcinoma. J Pathol 2002; 198:110-114.
44. Presti JC, Wilhelm M, Reuter V, et al. Allelic loss on chromosome 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney. J Urol 2002; 167:1464-1468.
45. Brauch H, Weirich G, Brieger J, et al. VHL alterations in human renal cell carcinoma: association with advanced tumor stage and novel hot spot mutation. Cancer Res 2000; 60:1942-1948.
46. Yao M, Yoshida M, Kishida T, et al. VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma. J Natl Cancer Inst 2002; 94:1569-1575.
47. Sweeney P, El-Naggar AK, Lin SH, Pisters LL. Biologic significance of c-met over-expression in papillary renal cell carcinoma. J Urol 2002; 168:51-55.
48. Rini BI, Vogelzang VJ. Prognostic factors in renal carcinoma. Semin Oncol 2000; 27:213-220.
49. Kanayama H, Yano S, Kim SJ, et al. Expression of vascular endothelial factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice. Clin Exp Met 1999; 17:831-840.
50. Kallio JP, Tammela TLJ, Marttinen AT, Kellokumpu P-LI. Soluble immunological parameters and early prognosis of renal cell cancer patients. J Exp Clin Cancer Res 2001; 20:523-527.
51. Hoffman R, Franzke A, Buer J, et al. Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma. Br J Cancer 1999; 79:1742-1745.
52. Hotakainen K, Ljungberg B, Haglund C, et al. Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum. Int J Cancer 2003; 104:631-635.
53. Parker AS, Cheville JC, Janney CA, Cerhan JR. High expression levels of insulin-like growth factor-1 receptor predict poor survival among women with clear-cell renal cell carcinomas. Hum Pathol 2002; 33:801-805.
54. Yoshida N, Ikemoto S, Narita K, et al. Interleukin-6, tumor necrosis factor alfa and interleukin-1beta in patients with renal cell carcinoma. Br J Cancer 2002; 86:1396-1400.
55. Bui MH, Seligson D, Han K, et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 2003; 9:802-811. This is an interesting study identifying a novel marker for RCC.
56. Mancilla-Jimenez R. Papillary renal cell carcinoma: a clinical, radiologic and pathologic study of 34 cases. Cancer 1976; 38:246-270.
57. Dekel Y, Koren R, Kugel V, et al. Significance of angiogenesis and microvascular invasion in renal cell carcinoma. Pathol Oncol Res 2002; 8:130-132.
58. Kirkali Z, Yorukoglu K, Ozkara E, et al. Proliferate activity, angiogenesis and nuclear morphometry in renal cell carcinoma. Int J Urol 2001; 8:697-703.
59. Sevinc M, Kirkali Z, Yorukoglu K, et al. Prognostic significance of microvascular invasion in localized renal cell carcinoma. Eur Urol 2000; 38:728-733.
60. Van Poppel H, Vandendriessche H, Boel H, et al. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. J Urol 1997; 158:45-49.
61. Feldman AL, Alexander HR, Yang CJ, et al. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer 2002; 95:1637-1643.
62. Wada S, Yoshimura R, Nagnuma T, et al. Thymidine phosphorylase levels as a prognostic factor in renal cell carcinoma. BJU Int 2003; 91:105-108.
63. Richter EN, Oevermann K, Buentig N, et al. Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinoma. J Urol 2002; 168:460-464.
64. Miyake H, Hara S, Arakawa S, et al. Overexpression of clusterin is an independent prognostic factor for nonpapillary renal cell carcinoma. J Urol 2002; 167:703-706.
65. O'Keefe SC, Marshall FF, Issa MM, et al. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 2002; 168:1378-1380.
66. Skinner DG, Colvin RV, Vermillion CD, et al. Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 1971; 28:1165-1177.
67. Sweeney JP, Thornhill JA, Graiger R, et al. Incidentally detected renal cell carcinoma: pathological features, survival trends and implication for treatment. Br J Urol 1996; 78:351-353.
68. Lee CT, Katz J, Feran PA, Russo P. Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol 2002; 7:135-140.
69. Blute ML, Itano NB, Cheville JC, et al. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol 2003; 169:1276-1281. This paper summarizes the effect of different pathological variables on the prognosis of sporadic RCC.
70. Pantuck AJ, Belldegrun AS, Figlin RA. Nephrectomy and interleukin-2 for metastatic renal cell carcinoma. N Eng J Med 2001; 345:1711-1716.
71. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared to interferon alfa-2b alone for metastatic renal-cell cancer. N Eng J Med 2001; 345:1655-1660.
72. Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared to interferon-alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001; 358:966-970.
73. Ljunberg B, Landberg G, Alamdari FI. Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol 2000; 34:246-251.
74. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002; 94:2511-2516. The importance of surgical technique is discussed in this paper.
75. Atzpodien J, Royston P, Wandert T, et al. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 2003; 88:348-353.
76. Zisman A, Pantuck AJ, Dorey F, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001; 19:1649-1657.
77. Mejean A, Oudard S, Thiounn N. Prognostic factors of renal cell carcinoma. J Urol 2003; 169:821-827. This is an excellent review of prognostic variables in patients with RCC. The classification of currently available prognostic markers is discussed in terms of tumor-, patient-and treatment-related factors.
78. Han KR, Bleumer I, Pantuck AJ, et al. International prognostication of renal cell carcinoma. J Urol 2003; 168 (Suppl):232.
79. Frank I, Blute ML, Cheville JC, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol 2002; 168:2395-2400. This paper outlines an innovative model for predicting outcome in patients with RCC